PNPG CAS: 3150-24-1 99% Pulvis alba
| Catalogue Number | XD90000 |
| Product Name | PNPG(4-Nitrophenyl-beta-D-galactopyranoside) |
| CAS | 3150-24-1 |
| Formulae hypotheticae | C12H15NO8 |
| M. Pondus | 301.25 |
| Repono Details | -15 ad -20 °C |
| Tariff Code harmonized | 29400000 |
Product Specification
| Aspectus | Solidus albus |
| Assay | 99% |
Our Business
XD BIOCHEM portfolio lato et integrato officiorum dat nostris clientibus et sociis in rebus pharmaceuticis, biotechicis et medicinis machinae industrias per orbem terrarum ad investigationes, explicandas, detegendas, et fructuosas curas curandas cito et efficaciter producunt.
XD BIOCHEM diversos clientium ordines praebet accessum amplis facultatibus et servitiis, ut omnia nova medicamenta quovis tempore R&D excolantur.Haec integrata, aperta accessus tribunal adiuvat claustra R&D deprimere et nova medicamenta aegris globaliter liberationem expedire.
XD BIOCHEM CRDMO operas praebet novas progressus medicamentorum ab inventione ad commercium, occurrentes quamcumque materiam exigentiam quacumque scala, et omnia genera ad omnes modales hypotheticas hypotheticas, inter parvas moleculas, oligonucleotidas, peptidas et complexas conjugatas.
biologia
Plenum spectrum biologiae operarum et solutionum, subsidia sola stantia et incepta integrata, ab inventione ad electionem candidatorum et in clinic.
Parvus Molecule (CRDMO)
Finem-ad-finem CRDMO Platform pro Parvus Molecule
Medicamento R&D et Medical Fabrica Testis
Comprehensiva, officia integrata solutiones a suggestu ad patientem obtinendum
Orci Research Services
Comprehensive Phase I-IV officia evolutionis clinicae
Oligonucleotide (CRDMO)
Finem-ad-finem CRDMO Platform pro Oligonucleotide
Peptide (CRDMO)
Finem-ad-finem CRDMO Platform pro Peptide
Cell Therapy and Gene Therapy
Solutiones ad explicandum therapiae crastinae vitam mutabilem provectae
